Top Stories
The move higher in Treasury yields over the past month has been…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Linda Llewelyn, the Chief People Officer at Health Catalyst , Inc.…
By Aida Pelaez-Fernandez MEXICO CITY (Reuters) – A majority of business…
Bennett C. Frank, Executive Vice President and Chief Scientific Officer at…
By Kanishka Singh WASHINGTON (Reuters) – The fatal 2019 arrest of…
Investments
The stock market exited the week stronger than it started, closing in…
Economy Insights
National News
SAN FRANCISCO—Dropbox, Inc. (NASDAQ:), a $9.5 billion cloud storage company with impressive 82% gross profit margins according to InvestingPro, saw its Chief Financial Officer Regan Timothy recently…
By Jonathan Stempel (Reuters) – The U.S. Equal Employment Opportunity (SO:) Commission on Friday sued two large automakers, accusing General Motors (NYSE:) and the United Auto Workers…
They’re stumped in Stumptown.Portland bills itself as a haven for cyclists, yet the Oregon city has struggled to reduce the rising death toll on its roadways, and…
Auriant Mining AB (the “Company”) announced on 14 October 2024 its plan to apply for delisting of the Company’s shares upon expiration of three months from the…
MILWAUKEE–(BUSINESS WIRE)–The Board of Directors of Sensient Technologies Corporation (NYSE: NYSE:) has declared a regular quarterly cash dividend on its common stock of $0.41 per share. The…
By Gram Slattery, Chris Prentice and Jarrett Renshaw WASHINGTON (Reuters) – President-elect Donald Trump is planning to use his executive powers to reduce the regulatory burden faced…